{"id":37364,"date":"2026-03-31T16:17:23","date_gmt":"2026-03-31T14:17:23","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=37364"},"modified":"2026-03-31T16:17:27","modified_gmt":"2026-03-31T14:17:27","slug":"nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/","title":{"rendered":"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Nederland en Denemarken zetten vaart achter een sterke Europese biotechagenda. Tijdens de EU\u2011Raad voor Concurrentievermogen eind februari riepen zij de Europese Commissie gezamenlijk op om te komen met een ambitieuze Biotech Act II die logisch voortbouwt op de recent gepresenteerde <a href=\"https:\/\/www.hollandbio.nl\/nieuws\/hollandbios-take-on-the-eu-biotech-act-part-i\/\">Biotech Act I<\/a>. Met een <a href=\"https:\/\/www.hollandbio.nl\/nieuws\/dutch-government-champions-broad-and-competitive-eu-biotech-act\/\">krachtige non\u2011paper<\/a> brachten zij deze oproep onder de aandacht van andere lidstaten \u2013 en met succes! Inmiddels scharen ook Portugal, Finland, Estland, Letland en Litouwen zich achter deze inzet. Wat deze lidstaten betreft, moet biotech de ruimte krijgen om te innoveren en op te schalen, wil Europa concurrerend blijven. En dat vraagt volgens hen om samenhangend beleid en het actief wegnemen van belemmeringen voor groei. Zij zetten erop in dat de Europese Commissie deze punten meeneemt in de verdere uitwerking van <a href=\"https:\/\/ec.europa.eu\/info\/law\/better-regulation\/have-your-say\/initiatives\/17394-Biotech-Act-II_en\">Biotech Act II<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nederland en Denemarken zetten vaart achter een sterke Europese biotechagenda. Tijdens de EU\u2011Raad voor Concurrentievermogen eind februari riepen zij de Europese Commissie gezamenlijk op om te komen met een ambitieuze Biotech Act II die logisch voortbouwt op de recent gepresenteerde Biotech Act I. Met een krachtige non\u2011paper brachten zij deze oproep onder de aandacht van [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[129],"tags":[],"class_list":["post-37364","post","type-post","status-publish","format-standard","hentry","category-eu-biotech-act"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nederland en Denemarken pleiten voor ambitieuze Biotech Act II - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II - hollandbio\" \/>\n<meta property=\"og:description\" content=\"Nederland en Denemarken zetten vaart achter een sterke Europese biotechagenda. Tijdens de EU\u2011Raad voor Concurrentievermogen eind februari riepen zij de Europese Commissie gezamenlijk op om te komen met een ambitieuze Biotech Act II die logisch voortbouwt op de recent gepresenteerde Biotech Act I. Met een krachtige non\u2011paper brachten zij deze oproep onder de aandacht van [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-31T14:17:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-31T14:17:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Idalia Dlugosz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Idalia Dlugosz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\\\/\"},\"author\":{\"name\":\"Idalia Dlugosz\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/20e3aa22ca991fdb93f4c843c0c0099c\"},\"headline\":\"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II\",\"datePublished\":\"2026-03-31T14:17:23+00:00\",\"dateModified\":\"2026-03-31T14:17:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\\\/\"},\"wordCount\":139,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"EU Biotech Act\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\\\/\",\"name\":\"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2026-03-31T14:17:23+00:00\",\"dateModified\":\"2026-03-31T14:17:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/20e3aa22ca991fdb93f4c843c0c0099c\",\"name\":\"Idalia Dlugosz\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/","og_locale":"en_US","og_type":"article","og_title":"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II - hollandbio","og_description":"Nederland en Denemarken zetten vaart achter een sterke Europese biotechagenda. Tijdens de EU\u2011Raad voor Concurrentievermogen eind februari riepen zij de Europese Commissie gezamenlijk op om te komen met een ambitieuze Biotech Act II die logisch voortbouwt op de recent gepresenteerde Biotech Act I. Met een krachtige non\u2011paper brachten zij deze oproep onder de aandacht van [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/","og_site_name":"hollandbio","article_published_time":"2026-03-31T14:17:23+00:00","article_modified_time":"2026-03-31T14:17:27+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"Idalia Dlugosz","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"Idalia Dlugosz","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/"},"author":{"name":"Idalia Dlugosz","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/20e3aa22ca991fdb93f4c843c0c0099c"},"headline":"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II","datePublished":"2026-03-31T14:17:23+00:00","dateModified":"2026-03-31T14:17:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/"},"wordCount":139,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["EU Biotech Act"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/","name":"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2026-03-31T14:17:23+00:00","dateModified":"2026-03-31T14:17:27+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederland-en-denemarken-pleiten-voor-ambitieuze-biotech-act-ii\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Nederland en Denemarken pleiten voor ambitieuze Biotech Act II"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/20e3aa22ca991fdb93f4c843c0c0099c","name":"Idalia Dlugosz"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/37364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=37364"}],"version-history":[{"count":1,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/37364\/revisions"}],"predecessor-version":[{"id":37365,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/37364\/revisions\/37365"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=37364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=37364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=37364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}